GlassScriptPhysician profile
Sean A Enkiri
NPI 1881816064
$17,623.23
in general payments reported to CMS, 2019-2025
43 companies · $5,433 in 2025
The $5,433 reported for 2025 was more than what 84% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,449 · 2020: $1,153 · 2021: $1,720 · 2022: $2,399 · 2023: $2,425 · 2024: $2,044 · 2025: $5,433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,124 · Travel and Lodging: $2,778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,124.45 |
| Travel and Lodging | $2,778.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,601.76 | 2019-2025 | Evoque, Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $2,752.18 | 2021-2025 | Corevalve Evolut R, Endurant Iis, Valiant Captivia |
| Shockwave Medical, INC | $2,182.82 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $1,943.26 | 2019-2025 | Rotablator Rotational Atherectomy System Console Kit |
| Abbott Laboratories | $1,383.65 | 2019-2025 | Mitraclip, Navitor, Triclip |
| Amgen INC. | $777.61 | 2019-2025 | Repatha, Repatha |
| Omega Medical Imaging, LLC | $419.63 | 2025 | |
| Novartis Pharmaceuticals Corporation | $332.84 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $311.99 | 2019-2025 | Farxiga, Lokelma |
| Medtronic Vascular, INC. | $277.87 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $268.28 | 2019-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $263.44 | 2019-2024 | Xarelto |
| Pfizer INC. | $243.27 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $175.24 | 2019-2025 | Jardiance |
| United Therapeutics Corporation | $138.66 | 2019-2025 | Tyvaso, Tyvaso |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Portola Pharmaceuticals, LLC | $136.00 | 2019-2020 | |
| Abiomed | $134.92 | 2024-2025 | Impella |
| Esperion Therapeutics, INC. | $123.06 | 2021-2025 | Nexletol |
| Sanofi-Aventis U.S. LLC | $119.82 | 2019 | |
| Heartflow, INC. | $115.93 | 2023-2025 | Ffrct |
| Livanova USA, INC. | $113.18 | 2019-2021 | |
| Novo Nordisk INC | $103.25 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| W. L. Gore & Associates, INC. | $71.86 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $59.06 | 2023-2025 | Verquvo, Winrevair |
| Lundbeck LLC | $56.12 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.81 | 2020-2025 | |
| Atricure, INC. | $49.25 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $48.10 | 2019-2021 | |
| Chiesi USA, INC. | $40.60 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $34.20 | 2019 | |
| Endologix LLC | $31.03 | 2025 | Endocross Device, Torus Stent Graft System |
| Genzyme Corporation | $30.31 | 2019 | |
| Azurity Pharmaceuticals, INC. | $29.55 | 2025 | Edarbi |
| Kiniksa Pharmaceuticals International, Plc | $29.44 | 2024 | Arcalyst |
| Cardiva Medical, INC. | $24.12 | 2022 | |
| Tactile Systems Technology INC | $22.25 | 2024 | Entre Plus, Flexitouch Plus |
| Biotronik INC. | $21.83 | 2023 | Orsiro Mission |
| Lilly USA, LLC | $19.17 | 2024 | Zepbound, Mounjaro |
| Philips North America LLC | $19.02 | 2024 | (Br5) Peripheral Ivus |
| Scpharmaceuticals INC. | $18.24 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.83 | 2021 | |
| Gilead Sciences, INC. | $13.99 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Enkiri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.